World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
56
Citations
9775
World Ranking
11789
National Ranking
3167

Raymond Baker publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Raymond Baker sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 394 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Raymond Baker D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond Baker sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 56 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 1994 - Fellow of the Royal Society, United Kingdom

Overview

Raymond Baker is affiliated with MSD in the United States. Their research primarily lies within the field of chemistry, with a particular focus on organic chemistry. Their work spans several subfields including molecular biology, pharmacology, computational theory and mathematics, and toxicology.

The scientist's research centers on various topics, including:

  • Synthesis and biological activity
  • Synthesis and Biological Evaluation
  • Multicomponent Synthesis of Heterocycles
  • Synthesis and Characterization of Heterocyclic Compounds
  • Quinazolinone synthesis and applications
  • Click Chemistry and Applications
  • Phenothiazines and Benzothiazines Synthesis and Activities

Recent significant papers authored or co-authored by Raymond Baker include:

  • "Synthesis of Chalcones Derivatives and Their Biological Activities: A Review" (2022), published in ACS Omega
  • "Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment" (2020), published in Medicinal Chemistry Research
  • "New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study" (2021), published in Molecules
  • "Efficient and Recoverable Bio-Organic Catalyst Cysteine for Synthesis, Docking Study, and Antifungal Activity of New Bio-Active 3,4-Dihydropyrimidin-2(1H)-ones/thiones Under Microwave Irradiation" (2022), published in ACS Omega
  • "Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights" (2020), published in Bioorganic & Medicinal Chemistry

Collaborations are an essential part of Raymond Baker's research, with frequent co-authors including:

  • Nadia A. A. Elkanzi
  • Mohamed A. Abdelgawad
  • Hajer Hrichi
  • Mohammed M. Ghoneim
  • Della Grace Thomas Parambi

Publications have appeared extensively in venues such as:

  • Chemistry & Biodiversity
  • Letters in Drug Design & Discovery
  • ACS Omega
  • Arabian Journal of Chemistry
  • Molecules

Raymond Baker was recognized as a Fellow of the Royal Society, United Kingdom, in 1994, an acknowledgment within the scientific community.

Best Publications

  • 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.

    P D Leeson;R W Carling;K W Moore;A M Moseley

  • Novel 5-HT3 antagonists. Indole oxadiazoles.

    C. J. Swain;R. Baker;C. Kneen;J. Moseley

  • Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

    John Saunders;Mark Cassidy;Stephen B. Freedman;Elizabeth A. Harley

  • Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.

    Paul D. Leeson;Raymond Baker;Robert W. Carling;Neil R. Curtis

  • Total Synthesis and Determination of the Absolute Configuration of Epibatidine

    Stephen R. Fletcher;Raymond Baker;Mark S. Chambers;Richard H. Herbert

  • Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.

    Frank Watjen;Raymond Baker;Mogens Engelstoff;Richard Herbert

  • Imidazole, triazole and tetrazole derivatives

    Raymond Baker;Victor G. Matassa;Leslie J. Street

  • Substituted morpholine derivatives and their use as therapeutic agents

    Raymond Baker;Timothy Harrison;Angus Murray Macleod;Andrew Pate Owens

  • Total synthesis of (+)-macbecin I

    Raymond Baker;Jose L. Castro

  • Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

    Michael Rowley;Janusz J. Kulagowski;Alan P. Watt;Denise Rathbone

  • 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones : orally active antagonists of the glycine site on the NMDA receptor

    Kulagowski Jj;Baker R;Curtis Nr;Leeson Pd

  • 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors.

    Rowley M;Broughton Hb;Collins I;Baker R

  • Identification and synthesis of the major sex pheromone of the olive fly (Dacus oleae)

    Raymond Baker;Richard Herbert;Philip E. Howse;Owen T. Jones

  • 2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the NMDA receptor.

    Robert W. Carling;Paul D. Leeson;Angela M. Moseley;Raymond Baker

  • Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors

    Leslie J. Street;Raymond Baker;Jose L. Castro;Mark S. Chambers

  • Spiropiperidines as high-affinity, selective .sigma. ligands.

    Mark S. Chambers;Raymond Baker;David C. Billington;Anthony K. Knight

  • Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy

    Raymond Baker;Christopher J. Swain;Martin R. Teall;Brian J. Williams

  • 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.

    Rowley M;Leeson Pd;Stevenson Gi;Moseley Am

  • Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them

    Raymond Baker;Timothy Harrison;Christopher John Swain;Brian John Williams

  • Pyrrolo-pyridine derivatives

    Raymond Baker;Neil Roy Curtis;Janusz Jozef Kulagowski;Paul David Leeson

  • .pi.-Allylmetal derivatives in organic synthesis

    Unknown

Frequent Co-Authors

Paul D. Leeson
Paul D. Leeson Loughborough University
Angus Murray Macleod
Angus Murray Macleod MSD (United States)
David A. Evans
David A. Evans Harvard University
Michael Rowley
Michael Rowley Pharmaron (United Kingdom)
Ian Collins
Ian Collins PharmEnable Therapeutics
Andrew B. Holmes
Andrew B. Holmes University of Melbourne
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Richard G. Ball
Richard G. Ball MSD (United States)
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Timothy M. Willson
Timothy M. Willson University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry opens doors to various online degree options and career trajectories. For students exploring flexible options, understanding the costs and structure is crucial. For example, students interested in fields like criminal justice can learn more about how much does a criminal justice degree cost, which helps in budgeting their education. Additionally, choosing an accredited online criminal justice associate degree ensures the quality and recognition of the program, a consideration that applies across disciplines, including chemistry-related careers.

For those interested in legal aspects tied to chemistry, such as patent law or regulatory compliance, understanding various degrees for paralegals can provide useful insights into complementary career paths. Moreover, chemistry graduates often find roles in pharmaceutical companies, where knowledge of the product is essential. Aspiring professionals may explore roles highlighted in pharma sales rep salary details to understand career opportunities and earning potential in the pharmaceutical sales sector.

Best Scientists Citing Raymond Baker

Recently Published Articles